The population density of New Boston, TX was 1,427 in 2017.
Population Density
Population Density is computed by dividing the total population by Land Area Per Square Mile.
Above charts are based on data from the U.S. Census American Community Survey | ODN Dataset | API -
Geographic and Population Datasets Involving New Boston, TX
- API
Key Economic Indicators
data.texas.gov | Last Updated 2024-10-01T21:22:37.000ZAn economic indicator is a statistic about an economic activity, and they allow analysis of economic performance and predictions of current and future economic performance. The TX Comptroller’s Key Economic Indicators includes such measures for TX & the US employment and unemployment, consumer confidence, price inflation, housing data, etc. See https://comptroller.texas.gov/about/policies/privacy.php for more information on our agency’s privacy and security policies.
- API
CPI 1.1 Texas Child Population (ages 0-17) by County 2014-2023
data.texas.gov | Last Updated 2024-09-05T21:23:24.000ZAs recommended by the Health and Human Services Commission (HHSC) to ensure consistency across all HHSC agencies, in 2012 DFPS adopted the HHSC methodology on how to categorize race and ethnicity. As a result, data broken down by race and ethnicity in 2012 and after is not directly comparable to race and ethnicity data in 2011 and before. The population totals may not match previously printed DFPS Data Books. Past population estimates are adjusted based on the U.S. Census data as it becomes available. This is important to keep the data in line with current best practices, but may cause some past counts, such as Abuse/Neglect Victims per 1,000 Texas Children, to be recalculated. Population Data Source - Population Estimates and Projections Program, Texas State Data Center, Office of the State Demographer and the Institute for Demographic and Socioeconomic Research, The University of Texas at San Antonio. Current population estimates and projections data as of December 2020. Visit dfps.texas.gov for information on all DFPS programs.
- API
Deer Tick Surveillance: Adults (Oct to Dec) excluding Powassan virus: Beginning 2008
health.data.ny.gov | Last Updated 2024-05-01T18:05:44.000ZThis dataset provides the results from collecting and testing adult deer ticks, also known as blacklegged ticks, or by their scientific name <i>Ixodes scapularis</i>. Collection and testing take place across New York State (excluding New York City) from October to December, when adult deer ticks are most commonly seen. Adult deer ticks are individually tested for different bacteria and parasites, which includes the bacteria responsible for Lyme disease. These data should simply be used to educate people that there is a risk of coming in contact with ticks and tick-borne diseases. These data only provide adult tick infections at a precise location and at one point in time. Both measures, tick population density and percentage, of ticks infected with the specified bacteria or parasite can vary greatly within a very small area and within a county. These data should not be used to broadly predict disease risk for a county. Further below on this page you can find links to tick prevention tips, a video on how to safely remove a tick, and more datasets with tick testing results. Interactive charts and maps provide an easier way to view the data.
- API
Deer Tick Surveillance: Nymphs (May to Sept) excluding Powassan virus: Beginning 2008
health.data.ny.gov | Last Updated 2024-05-01T18:07:53.000ZThis dataset provides the results from collecting and testing nymph deer ticks, also known as blacklegged ticks, or by their scientific name <i>Ixodes scapularis</i>. Collection and testing take place across New York State (excluding New York City) from May to September, when nymph deer ticks are most commonly seen. Nymph deer ticks are individually tested for different bacteria and parasites, which includes the bacteria responsible for Lyme disease. These data should simply be used to educate people that there is a risk of coming in contact with ticks and tick-borne diseases. These data only provide nymph tick infections at a precise location and at one point in time. Both measures, tick population density and percentage, of ticks infected with the specified bacteria or parasite can vary greatly within a very small area and within a county. These data should not be used to broadly predict disease risk for a county. Further below on this page you can find links to tick prevention tips, a video on how to safely remove a tick, and more datasets with tick testing results. Interactive charts and maps provide an easier way to view the data.
- API
Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status
data.cdc.gov | Last Updated 2023-07-20T16:01:58.000ZData for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022. Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases
- API
Deer Tick Surveillance: Nymphs (May to Sept) Powassan Virus Only: Beginning 2009
health.data.ny.gov | Last Updated 2024-05-01T18:00:16.000ZThis dataset provides the results from collecting and testing nymph deer ticks, also known as blacklegged ticks, or by their scientific name <i>Ixodes scapularis</i>. Collection and testing take place across New York State (excluding New York City) from May to September, when nymph deer ticks are most commonly seen. Nymph deer ticks are tested in “pools”, or groups of up to ten adult ticks per pool, for the Powassan virus, also known as Deer tick virus. These data should simply be used to educate people that there is a risk of coming in contact with ticks and tick-borne diseases. These data only provide nymph tick minimum infection rates at a precise location and at one point in time. Both measures, tick population density and minimum infection percentages, can vary greatly within a very small area and within a county. These data should not be used to broadly predict disease risk for a county. Further below on this page you can find links to tick prevention tips, a video on how to safely remove a tick, and more datasets with tick testing results. Interactive charts and maps provide an easier way to view the data.
- API
Deer Tick Surveillance: Adults (Oct to Dec) Powassan Virus Only: Beginning 2009
health.data.ny.gov | Last Updated 2024-05-01T18:04:12.000ZThis dataset provides the results from collecting and testing adult deer ticks, also known as blacklegged ticks, or by their scientific name Ixodes scapularis. Collection and testing take place across New York State (excluding New York City) from October to December, when adult deer ticks are most commonly seen. Adult deer ticks are tested in “pools”, or groups of up to ten adult ticks per pool, for the Powassan virus, also known as Deer tick virus. These data should simply be used to educate people that there is a risk of coming in contact with ticks and tick-borne diseases. These data only provide adult tick minimum infection rates at a precise location and at a point in time. Both measures, tick population density and minimum infection percentages, can vary greatly within a very small area and within a county. These data should not be used to broadly predict disease risk for a county. Further below on this page you can find links to tick prevention tips, a video on how to safely remove a tick, and more datasets with tick testing results. Interactive charts and maps provide an easier way to view the data.
- API
New Brunswick Population Characteristics 1986 -2006 / Caractéristiques de la population du Nouveau-Brunswick 1986 -2006
gnb.socrata.com | Last Updated 2019-07-12T13:06:01.000ZAn overview of population totals for both urban and rural areas of New Brunswick / Un aperçu des totaux de population pour les zones urbaines et rurales du Nouveau-Brunswick
- API
COVID-19 Vaccine Distribution Allocations by Jurisdiction - Pfizer
data.cdc.gov | Last Updated 2021-06-17T12:52:14.000ZNew weekly allocations of doses are posted every Tuesday. Beginning the following Thursday, states can begin ordering doses from that week’s new allocation of 1st doses. Beginning two weeks (Pfizer) or three weeks (Moderna) from the following Sunday, states can begin ordering doses from that week’s new allocation of 2nd doses. After doses are ordered by states, shipments begin the following Monday. The entire order may not arrive in one shipment or on one day, but over the course of the week. Second doses are opened up for orders on Sundays, at the appropriate interval two or three weeks later according to the manufacturer’s label, with shipments occurring after jurisdictions place orders. Shipments of an FDA-authorized safe and effective COVID-19 vaccine continue to arrive at sites across America. Vaccinations began on December 14, 2020. https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html Moderna Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/b7pe-5nws Janssen Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/w9zu-fywh
- API
COVID-19 Vaccine Distribution Allocations by Jurisdiction - Moderna
data.cdc.gov | Last Updated 2021-06-17T12:52:51.000ZNew weekly allocations of doses are posted every Tuesday. Beginning the following Thursday, states can begin ordering doses from that week’s new allocation of 1st doses. Beginning two weeks (Pfizer) or three weeks (Moderna) from the following Sunday, states can begin ordering doses from that week’s new allocation of 2nd doses. After doses are ordered by states, shipments begin the following Monday. The entire order may not arrive in one shipment or on one day, but over the course of the week. Second doses are opened up for orders on Sundays, at the appropriate interval two or three weeks later according to the manufacturer’s label, with shipments occurring after jurisdictions place orders. Shipments of an FDA-authorized safe and effective COVID-19 vaccine continue to arrive at sites across America. Vaccinations began on December 14, 2020. https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html Pfizer Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Initial-Allocations-Pfizer/saz5-9hgg Janssen Vaccine Data - https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/w9zu-fywh